Eterna Therapeutics (ERNA) Fails to deliver data

Key failure to deliver metrics for Eterna Therapeutics:

• Last SEC data release: 2026-09-14
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: N/A
• Last 12 months FTD volume: £4.59 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Eterna Therapeutics (ERNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Eterna Therapeutics (ERNA) - since 2025

Eterna Therapeutics (ERNA) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Sanofi SNY	£14.8 M	£32.98 M	🇫🇷 France
Baxter BAX	£9.7 M	£81.91 M	🇺🇸 USA
Omeros Corporation OMER	£13.79 M	£43.81 M	🇺🇸 USA
Geron GERN	£1.77 M	£5.6 M	🇺🇸 USA
Genetic Technologies GENE	N/A	£0 M	🇦🇺 Australia
Teva Pharmaceutical Industries TEVA	£7.71 M	£75 M	🇮🇱 Israel
Bio-Techne TECH	£32.89 M	£0.13 B	🇺🇸 USA